Technology area: Biotechnology & Pharmaceuticals
8 pending office actions • 5 art units • 7 examiners • 2 of 8 (25%) have an AI response strategy ready • 8 patents granted in the last 365 days
Qingdao Kingagroot Chemical Compound Co. Ltd. has 8 pending office actions in Biotechnology & Pharmaceuticals. The matters are distributed among 7 distinct examiners and 5 distinct art units, showing both examiner assignment spread and some concentration at the art unit level. The action volume exceeds the examiner count, so at least one examiner handles more than one pending matter.
HIRT, ERIN E is the busiest examiner, with 2 pending matters. That assignment is a useful coordination point, but it does not represent the entire portfolio. Counsel should align recurring chemical and pharmaceutical claim positions while tailoring responses to the separate examiner and art unit contexts.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (25%) |
| §102 only | 1 (12%) |
| §112 only | 2 (25%) |
| Double-patenting + other | 1 (12%) |
| Multi-statute (no §101) | 2 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HIRT, ERIN E | 2 | 40.6% | +22.9% |
| MEYER, GEORGE WILLIAM | 1 | 100.0% | +0.0% |
| PAK, YONG D | 1 | 74.7% | +14.2% |
| MCWILLIAMS, KELSEY LYNN | 1 | 89.2% | +5.8% |
| O DELL, DAVID K | 1 | 57.7% | +36.0% |
| PALLAY, MICHAEL B | 1 | 55.8% | +33.8% |
| SHARMA, SANTOSH | 1 | 72.8% | +29.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18019498 | HERBICIDE-RESISTANT PROTEIN, AND GENE AND USE THEREOF | MCWILLIAMS, KELSEY LYNN | 7d |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18838151 | PPO2 POLYPEPTIDE HAVING TOLERANCE TO PPO INHIBITOR HERBICIDE AND APPLICATION | MEYER, GEORGE WILLIAM | — |
| 18842536 | ENGINEERED NUCLEASE AND USE THEREOF | PAK, YONG D | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17627221 | HERBICIDAL COMPOSITION CONTAINING R-TYPE PYRIDYLOXY CARBOXYLIC ACID DERIVATIVE AND USE THEREOF | PALLAY, MICHAEL B | 12d |
| 17628334 | CARBOXYLIC ACID DERIVATIVE-SUBSTITUTED IMINO ARYL COMPOUND, PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION AND USE THEREOF | HIRT, ERIN E | 28d |
| 18848548 | HETEROCYCLE-SUBSTITUTED AROMATIC COMPOUND, METHOD FOR PREPARING SAME, HERBICIDAL COMPOSITION, AND USE THEREOF | HIRT, ERIN E | — |
| 18842536 | ENGINEERED NUCLEASE AND USE THEREOF | PAK, YONG D | — |
| 17774763 | SUBSTITUTED THIAZOLE AROMATIC RING-BASED COMPOUND AND PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION AND USE THEREOF | O DELL, DAVID K | — |
| 17058261 | A METHOD FOR GENERATING NEW MUTATION IN ORGANISM AND USE THEREOF | SHARMA, SANTOSH | — |
| Art Unit | Apps |
|---|---|
| 1616 | 2 |
| 1663 | 2 |
| 1662 | 1 |
| 1621 | 1 |
| 1617 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18838151 | PPO2 POLYPEPTIDE HAVING TOLERANCE TO PPO INHIBITOR HERBICIDE AND APPLICATION | MEYER, GEORGE WILLIAM | 1662 | §102§112 | Non-Final OA | — | Pending | Apr 03, 2025 |
| 18848548 | HETEROCYCLE-SUBSTITUTED AROMATIC COMPOUND, METHOD FOR PREPARING SAME, HERBICIDAL COMPOSITION, AND USE THEREOF | HIRT, ERIN E | 1616 | §102§103§112DP | Non-Final OA | — | Pending | Sep 19, 2024 |
| 18842536 | ENGINEERED NUCLEASE AND USE THEREOF | PAK, YONG D | — | §102§103§112 | Non-Final OA | — | Pending | Aug 29, 2024 |
| 18019498 | HERBICIDE-RESISTANT PROTEIN, AND GENE AND USE THEREOF | MCWILLIAMS, KELSEY LYNN | 1663 | §112 | Non-Final OA | 7d | Pending | Feb 03, 2023 |
| 17774763 | SUBSTITUTED THIAZOLE AROMATIC RING-BASED COMPOUND AND PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION AND USE THEREOF | O DELL, DAVID K | 1621 | §112 | Non-Final OA | — | Pending | May 05, 2022 |
| 17628334 | CARBOXYLIC ACID DERIVATIVE-SUBSTITUTED IMINO ARYL COMPOUND, PREPARATION METHOD THEREFOR, HERBICIDAL COMPOSITION AND USE THEREOF | HIRT, ERIN E | 1616 | §103Other | Final Rejection | 28d | AI Ready | Jan 19, 2022 |
| 17627221 | HERBICIDAL COMPOSITION CONTAINING R-TYPE PYRIDYLOXY CARBOXYLIC ACID DERIVATIVE AND USE THEREOF | PALLAY, MICHAEL B | 1617 | §103 | Non-Final OA | 12d | AI Ready | Jan 14, 2022 |
| 17058261 | A METHOD FOR GENERATING NEW MUTATION IN ORGANISM AND USE THEREOF | SHARMA, SANTOSH | 1663 | §102 | Non-Final OA | — | Pending | Nov 24, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialQingdao Kingagroot Chemical Compound Co. Ltd. has 8 pending office actions as of October 2026, spread across 5 art units and 7 examiners.
Erin E Hirt has the most, with 2 of Qingdao Kingagroot Chemical Compound Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
